8PK-27647-10138
4 vaccinations
11 coded responses
46 check-ins
12 free-text entries
7 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 220 / VA
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-10
Registered in v-safe
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
-
2021-04-23
Survey response — day 14, dose 1MedDRA: Pre-existing disease, Vertigo — Feeling: Good · Be unable to workFree text: Independent of receiving a vaccine, I have a history of experiencing symptoms of vertigo since 2014, which tends to increase in the Spring with the pollen count. Which can result in missing a day of work. Such was the scenario this week.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Dose 2 — Pfizer-BioNTech
- 2021-04-30
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-02
Survey response — days 1–6 daily, dose 2MedDRA: Abdominal discomfort, Abdominal pain, Chest discomfort, Emergency care, Musculoskeletal chest pain, Unevaluable event — Feeling: Poor · Site: Pain · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Systemic reaction (other): Pressurized discomfort pain throughout abdominal and rib cage with chest tightness requiring ER care and testing · Healthcare visit (other): In the midst of cardiac and abdominal work-up at (b)(6)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-02
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Abdominal pain · Be unable to work or attend schoolAdult check-in
- 2021-05-05
- 2021-05-06
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-11
-
2021-07-30
Survey response — 3 months, dose 2MedDRA: Drug therapeutic incompatibility — Feeling: Fair · Be unable to work or attend schoolFree text: Increase sensitivity to anti-vertigo medications (meclizine).MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-29
Survey response — 6 months, dose 2MedDRA: Dyspnoea, Vertigo — Feeling: Fair · Be unable to work or attend schoolFree text: Episodes of shortness of breath. Increase sensitivity to vertigo medications (e.g., extended sedation).MedDRA releases: 2024-11 · check-in free text available
- 2022-01-10
-
2022-01-21
Dose 3 — Pfizer-BioNTech
-
2022-01-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-01-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2022-01-26
-
2022-01-27
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-01-29
- 2022-02-04
-
2022-02-11
Survey response — day 21, dose 3MedDRA: Heart rate increased, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Extremely high and frequent heart rate. · Healthcare visit (other): Lab Work and medications ordered and cardiac specialty consult with an electrophysiologist being coordinated.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-11
Report sent to call center — day 21, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-17
-
2022-02-20
Survey response — day 28, dose 3MedDRA: Tachycardia, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Continued tachycardia. Adjusting to a newly ordered cardiac medication which has been sedating. · Healthcare visit (other): Cardiac medication and lab work ordered follow-up appointment with electrophysiologist scheduled.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-20
Report sent to call center — day 28, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-21
-
2022-02-21
Call successfulCompleted over the phone
-
2022-02-25
Survey response — day 35, dose 3MedDRA: Arrhythmia, Tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: In the midst of cardiac monitoring for tachycardia and arrhythmias.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-25
Report sent to call center — day 35, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-02
-
2022-03-05
Survey response — day 42, dose 3MedDRA: Arrhythmia, Medical counselling, Tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: I am under medical care for arrhythmias and tachycardia.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-05
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-08
-
2022-07-22
Survey response — 6 months, dose 3MedDRA: Arrhythmia, Gallbladder operation — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Symptoms: Cardiac arrhythmias and gallbladder surgery. · Healthcare visit (other): Gallbladder SurgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-07-22
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2022-07-25
- 2022-07-28
-
2022-09-20
Call successfulParticipant prefers to complete VAERS report online
-
2022-09-20
Call successfulParticipant prefers to complete VAERS report online
-
2022-09-20
Call successfulParticipant prefers to complete VAERS report online
-
2022-09-20
Call successfulParticipant prefers to complete VAERS report online
-
2022-09-20
Call successfulParticipant prefers to complete VAERS report online
-
2022-09-24
Dose 4 — Pfizer-BioNTech
- 2022-09-24
-
2022-09-26
Survey response — days 1–6 daily, dose 4MedDRA: Feeling hot — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Hot/Warm SpellsMedDRA releases: 2024-11 · check-in free text available
-
2022-09-29
Survey response — days 1–6 daily, dose 4MedDRA: Hot flush — Feeling: Fair · Fatigue or tirednessFree text: Hot FlashesMedDRA releases: 2024-11 · check-in free text available
- 2022-09-30
- 2022-10-01
- 2022-10-10
- 2022-10-15
- 2022-10-24
- 2022-10-29
- 2022-11-05
-
2022-12-24
Health check-in — 3 months, dose 4Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: A severe upper respiratory infection, which after 1.5 weeks required treatment with an antibiotic (Amoxicillin).Adult check-in · check-in free text available
-
2022-12-24
Call case (no matching report) — SuccessfulCompleted over the phone
-
2022-12-28
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech | |
| 3 | 2022-01-21 | Pfizer-BioNTech | No |
| 4 | 2022-09-24 | Pfizer-BioNTech | No |
Call center
7 call center cases
7 successful
VAERS report filed, before or during a call: 2
1 wait over 3 months for a first call
Free text
Release 7 — day 14, dose 1
Symptoms: Independent of receiving a vaccine, I have a history of experiencing symptoms of vertigo since 2014, which tends to increase in the Spring with the pollen count. Which can result in missing a day of work. Such was the scenario this week.
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Pressurized discomfort pain throughout abdominal and rib cage with chest tightness requiring ER care and testing
Healthcare visit (other): In the midst of cardiac and abdominal work-up at (b)(6)
redacted (b)(6)
Release 9 — 3 months, dose 2
Symptoms: Increase sensitivity to anti-vertigo medications (meclizine).
Release 10 — 6 months, dose 2
Symptoms: Episodes of shortness of breath. Increase sensitivity to vertigo medications (e.g., extended sedation).
Release 11 — day 21, dose 3
Symptoms: Extremely high and frequent heart rate.
Healthcare visit (other): Lab Work and medications ordered and cardiac specialty consult with an electrophysiologist being coordinated.
Release 11 — day 28, dose 3
Symptoms: Continued tachycardia. Adjusting to a newly ordered cardiac medication which has been sedating.
Healthcare visit (other): Cardiac medication and lab work ordered follow-up appointment with electrophysiologist scheduled.
Release 11 — day 35, dose 3
Symptoms: In the midst of cardiac monitoring for tachycardia and arrhythmias.
Release 11 — day 42, dose 3
Symptoms: I am under medical care for arrhythmias and tachycardia.
Release 12 — 6 months, dose 3
Symptoms: Cardiac arrhythmias and gallbladder surgery.
Healthcare visit (other): Gallbladder Surgery
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Hot/Warm Spells
Systemic reaction (other): Hot Flashes
Release 12 — 3 months, dose 4
Symptoms: A severe upper respiratory infection, which after 1.5 weeks required treatment with an antibiotic (Amoxicillin).
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Gallbladder operation | · | · | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Arrhythmia | · | · | ✓ |
| SD | Drug therapeutic incompatibility | ✓ | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Gallbladder operation | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Medical counselling | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
| SRO | Abdominal discomfort | ✓ | ✓ | ✓ |
| SRO | Abdominal pain | ✓ | ✓ | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Emergency care | ✓ | ✓ | ✓ |
| SRO | Feeling hot | · | · | ✓ |
| SRO | Hot flush | · | · | ✓ |
| SRO | Musculoskeletal chest pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release